Target- |
Mechanism- |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
M-02胶囊在健康受试者中多次给药的安全性、耐受性及药动学研究
[Translation] Safety, tolerability and pharmacokinetics of M-02 capsules after repeated administration in healthy subjects
主要目的:评价M-02胶囊在健康受试者中多次口服给药的安全性与耐受性。次要目的:评价M-02胶囊在健康受试者中多次给药的药代动力学(PK)特征。
[Translation] Primary objective: To evaluate the safety and tolerability of multiple oral administration of M-02 capsules in healthy subjects. Secondary objective: To evaluate the pharmacokinetic (PK) characteristics of multiple oral administration of M-02 capsules in healthy subjects.
M-02胶囊在健康受试者中单次给药的安全性、耐受性及药动学研究
[Translation] Safety, tolerability and pharmacokinetics of single-dose M-02 capsules in healthy subjects
主要目的:评价M-02胶囊在健康受试者中单次口服给药的安全性与耐受性。
次要目的:评价M-02胶囊在健康受试者中单次给药的药代动力学(PK)特征。
[Translation] Primary objective: To evaluate the safety and tolerability of a single oral administration of M-02 capsules in healthy subjects.
Secondary objective: To evaluate the pharmacokinetic (PK) characteristics of a single oral administration of M-02 capsules in healthy subjects.
100 Clinical Results associated with Shanghai Hanmai Biomedical Technology Co., Ltd.
0 Patents (Medical) associated with Shanghai Hanmai Biomedical Technology Co., Ltd.
100 Deals associated with Shanghai Hanmai Biomedical Technology Co., Ltd.
100 Translational Medicine associated with Shanghai Hanmai Biomedical Technology Co., Ltd.